View Older Stories View More Recent Stories
-
TriSummit Utilities Inc. Closes $200 Million Medium-Term Note Offering
-
RBC Capital Upgrades Pan Am Silver (PAAS) to Outperform
-
Redwood Trust (RWT) Prices 2.6M Preferred Share Offering
-
Redwood Trust Announces Pricing of Public Offering of Preferred Stock
-
Illumina (ILMN) shares slump on weaker than forecast 2023 profit guidance
-
Form MA-I RBC Capital Markets,
-
RBC Capital on Biogen (BIIB): 'FDA Summary Review Now Available; We Believe Suggests High Amenability For Future Full Leca Approval'
-
Aquarian Closes Acquisition of Somerset Reinsurance
-
Air Lease (AL) Prices $700M Senior Unsecured Medium-Term Notes Offering
-
RBC Capital Upgrades Warehouse Reit PLC (WHR:LN) to Sector Perform
-
Air Lease Corporation Announces Pricing of Public Offering of $700.0 Million of Senior Unsecured Medium-Term Notes
-
TriSummit Utilities Inc. Announces $200 Million Medium-Term Note Offering
-
First Capital REIT Comments on Litigation By Sandpiper and Artis REIT
-
Sun Communities (SUI) Prices $400M Senior Notes Offering
-
Sun Communities, Inc. Prices $400 Million of Senior Notes
-
Sun Communities, Inc. Prices $400 Million of Senior Notes
-
Today's most important downgrades
-
Crown Castle (CCI) Prices $1B Senior Notes Offering
-
Crown Castle Announces Pricing of Senior Notes Offering
-
RBC Capital Downgrades Medtronic, Inc. (MDT) to Sector Perform
-
RBC GAM launches RBC Emerging Markets ex-China Equity Fund in U.S.
-
Crown Castle (CCI) Announces Proposed Notes Offering, Size not Disclosed
-
Crown Castle Announces Proposed Offering of Senior Notes
-
Nuvei Corporation (NVEI) Acquires Paya (PAYA) for $9.75/sh Cash or $1.3B
-
Nuvei Enters Definitive Agreement to Acquire Paya
-
Nuvei Enters Definitive Agreement to Acquire Paya
-
Biogen (BIIB) gains ahead of lecanemab PDUFA
-
Canadian dollar to rebound in 2023 if economic uncertainty clears: Reuters poll
-
RBC Capital on Biogen (BIIB): 'a very favorable stock setup'
-
Sunrun (RUN) Closes $835 Million Non-Recourse Financings to Support Continued Growth
-
Sunrun Closes $835 Million Non-Recourse Financings to Support Continued Growth
-
Sunrun Closes $835 Million Non-Recourse Financings to Support Continued Growth
-
RBC Capital on Prometheus Biosciences Inc (RXDX): 'continue to see PRA023 with best-in-class potential in UC'
-
ICR, the Leading SPAC Communications and Advisory Firm, Publishes Q4 2022 SPAC Market Update
-
Salesforce to cut 10% of workforce after hiring "too many people"
-
RBC Capital Upgrades Celanese (CE) to Outperform
-
Enterprise Products (EPD) Prices $1.75B Senior Notes Offering
-
Enterprise Prices $1.75 Billion Aggregate Principal Amount of Senior Notes
-
Aurinia Pharmaceuticals (AUPH) PT Raised to $11 at RBC Capital Following Settlement
-
Tesla (TSLA) PT Lowered to $186 at RBC Capital, '4Q22 deliveries miss, could spark lower mid-term expectations'
-
APCO Holdings, LLC, Acquires National Auto Care, Creating Nationwide F&I Force
-
Gilead (GILD) stock downgraded at RBC as analyst sees shares range-bound in 2023
-
RBC Capital Downgrades Gilead Sciences (GILD) to Sector Perform
-
RBC Capital Downgrades Traeger Inc. (COOK) to Sector Perform
-
RBC Capital Downgrades Mondelez International (MDLZ) to Sector Perform
-
Today's most important initiations
-
Form MA-I/A RBC Capital Markets,
-
As Bank of Japan switches gears, roaring dollar hits the skids
-
Form X-17A-5 RBC CAPITAL MARKETS, For: Oct 31
-
RBC Capital on Karuna Therapeutics Inc. (KRTX) via Cerevel (CERE) Data: 'KarXT sets a high bar for future muscarinic agents'
